|
Orthologous residues
|
|
VAMP2 (human): T35‑p, VAMP2 (mouse): T35‑p, VAMP2 (rat): T35‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Disease tissue studied:
neuroblastoma
|
|
Relevant cell lines - cell types - tissues:
N2a (neuron)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATR (mouse)
|
microscopy-colocalization, siRNA inhibition of enzyme, co-immunoprecipitation, modification site within consensus motif
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
ATM (mouse)
|
|
Induces
|
molecular association, regulation
|
|
co-immunoprecipitation
|
|
|
Comments:
complex of ATM, VAMP2, ATR and SYN1
|